Ronald Lizée
Direttore Finanziario/CFO presso Acrongenomics, Inc.
Profilo
Ronald Lizée is currently the President & Chief Executive Officer at Gemstar Capital Properties, Inc. He is also the Chief Financial Officer at Acrongenomics, Inc. Previously, he served as the Chief Financial Officer, Treasurer & Director at PreAxia Health Care Payment Systems, Inc. from 2008 to 2011.
Additionally, he was the Chief Financial Officer at Sun World Partners, Inc. from 2008 to 2009.
Mr. Lizée obtained his undergraduate degree from the University of Saskatchewan in 1981.
Posizioni attive di Ronald Lizée
| Società | Posizione | Inizio |
|---|---|---|
Acrongenomics, Inc.
 Acrongenomics, Inc. Medical SpecialtiesHealth Technology Acrongenomics, Inc. engages in the development and commercialization ofnovel biotechnology platforms in the Life Science sector as well as introducing and developing new compounds in the Pharmaceutical sector. The company was founded on August 17, 1999 and is headquartered in London, the United Kingdom. | Direttore Finanziario/CFO | 04/06/2004 |
| Gemstar Capital Properties, Inc. | Amministratore Delegato | 02/03/2010 |
Precedenti posizioni note di Ronald Lizée
| Società | Posizione | Fine |
|---|---|---|
| PREAXIA HEALTH CARE PAYMENT SYSTEMS INC. | Direttore Finanziario/CFO | 24/11/2011 |
| Sun World Partners, Inc. | Direttore Finanziario/CFO | 15/01/2009 |
Formazione di Ronald Lizée
| University of Saskatchewan | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PREAXIA HEALTH CARE PAYMENT SYSTEMS INC. | Technology Services |
| Aziende private | 3 |
|---|---|
Acrongenomics, Inc.
Acrongenomics, Inc. Medical SpecialtiesHealth Technology Acrongenomics, Inc. engages in the development and commercialization ofnovel biotechnology platforms in the Life Science sector as well as introducing and developing new compounds in the Pharmaceutical sector. The company was founded on August 17, 1999 and is headquartered in London, the United Kingdom. | Health Technology |
| Sun World Partners, Inc. | Retail Trade |
| Gemstar Capital Properties, Inc. |
- Borsa valori
- Insiders
- Ronald Lizée
